Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies

Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies

Systemic autoimmune diseases (SAIDs), such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc) and rheumatoid arthritis (RA), are fully related to the unregulated innate and adaptive immune systems involved in their pathogenesis. They have similar pathogenic characteristics, including th...

Full description

Bibliographic Details
Main Authors:	Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, Elvina Gilyazova, Damir Davletshin, Marat Khaliulin, Emmanuel Kabwe, Yuriy N. Davidyuk, Aygul Valiullina, Albert Rizvanov, Emil Bulatov
Format:	Article
Language:	English
Published:	MDPI AG 2024-02-01
Series:	Antibodies
Subjects:	immunotherapy autoimmune diseases monoclonal antibodies bispecific antibodies CAR-T cells
Online Access:	https://www.mdpi.com/2073-4468/13/1/10

Similar Items

Cell-Based Therapy and Genome Editing as Emerging Therapeutic Approaches to Treat Rheumatoid Arthritis
by: Vitaly Chasov, et al.
Published: (2024-07-01)

Gut Microbiota Modulation: A Novel Strategy for Rheumatoid Arthritis Therapy
by: Vitaly Chasov, et al.
Published: (2024-12-01)

Advances in Emerging Therapies for Multiple Myeloma
by: QIAN Chenjing, et al.
Published: (2023-03-01)

Emerging Trends in Immunotherapy for Cancer
by: Alok K. Mishra, et al.
Published: (2022-09-01)

Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections
by: Ekaterina Zmievskaya, et al.
Published: (2021-01-01)

Broadly protective bispecific antibodies that simultaneously target influenza virus hemagglutinin and neuraminidase
by: Kevin E. Ramos, et al.
Published: (2024-07-01)

NK Cell-Based Immunotherapy in Colorectal Cancer
by: Mariella Della Chiesa, et al.
Published: (2022-06-01)

Producing and prospects for the use of bispecific antibodies for the treatment of cancer
by: S. E. Sedykh, et al.
Published: (2019-01-01)

Regulatory considerations in the design, development and quality of monoclonal antibodies and related products for the diagnosis and treatment of cancer
by: Marjorie A. Shapiro
Published: (2024-04-01)

Editorial: Therapeutic antibody domains against cancer
by: Qi Zhao, et al.
Published: (2023-08-01)

Immunotherapy with Antibodies in Multiple Myeloma: Monoclonals, Bispecifics, and Immunoconjugates
by: Christie P. M. Verkleij, et al.
Published: (2021-03-01)

The Role of Autologous Stem Cell Transplantation in the Treatment of Newly Diagnosed Multiple Myeloma: Is It Time to Rethink the Paradigm in the Era of Targeted Therapy?
by: Paul G. Richardson
Published: (2024-04-01)

Identification of mpox M1R and B6R monoclonal and bispecific antibodies that efficiently neutralize authentic mpox virus
by: Zuning Ren, et al.
Published: (2024-12-01)

Bispecific antibodies and dual-targeting CAR-T cells for multiple myeloma: latest updates from the 2023 ASCO annual meeting
by: Jiangxue Hou, et al.
Published: (2023-08-01)

Emerging technology trends in regulatory approvals of cancer immunotherapy drugs by the FDA and EMA
by: Maryam Monajati, et al.
Published: (2024-09-01)

Identification and Targeting of Mutant Neoantigens in Multiple Myeloma Treatment
by: Valentina Urzì Brancati, et al.
Published: (2023-04-01)

A tailored lectin microarray for rapid glycan profiling of therapeutic monoclonal antibodies
by: Shen Luo, et al.
Published: (2024-12-01)

Advancing Multiple Myeloma Immunotherapy: A Review of Chimeric Antigen Receptor T-Cell and Bispecific T-Cell Engagers Cell Therapies in Revolutionizing Treatment
by: Rahul Navab, et al.
Published: (2025-01-01)

DEVELOPMENTS OF RUSSIAN ORIGINAL BIOLOGICAL AGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY RHEUMATIC DISEASES
by: E. L. Nasonov, et al.
Published: (2017-04-01)

Anticalin N- or C-Terminal on a Monoclonal Antibody Affects Both Production and In Vitro Functionality
by: Nicolas Aubrey, et al.
Published: (2022-08-01)

Recent Advances in the Development of Bioreactors for Manufacturing of Adoptive Cell Immunotherapies
by: Irina Ganeeva, et al.
Published: (2022-12-01)

Large-scale production of monoclonal antibodies in suspension culture /
by: 271860 Backer, M. P., et al.

Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses
by: Antonio Tapia-Galisteo, et al.
Published: (2024-12-01)

Editorial: Molecular pharmacological approaches against lung diseases: targeted drug discovery
by: Poonam Arora, et al.
Published: (2024-07-01)

Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation properties
by: Abdullah Elsayed, et al.
Published: (2023-12-01)

Advances in <i>Escherichia coli</i>-Based Therapeutic Protein Expression: Mammalian Conversion, Continuous Manufacturing, and Cell-Free Production
by: Sarfaraz K. Niazi, et al.
Published: (2023-11-01)

Herpesvirus Infections After Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies: A Review
by: Joseph Sassine, et al.
Published: (2025-01-01)

Logic-gated and contextual control of immunotherapy for solid tumors: contrasting multi-specific T cell engagers and CAR-T cell therapies
by: Olivier Nolan-Stevaux, et al.
Published: (2024-11-01)

Visualizing immunotherapy for multiple myeloma worldwide from 2013 to 2023: A bibliometric analysis
by: Jinqiao Li, et al.
Published: (2024-12-01)

Targeting Herpes Simplex Virus Glycoprotein D with Bispecific Antibodies: Expanding Therapeutic Horizons by Searching for Synergy
by: Doina Atanasiu, et al.
Published: (2025-02-01)

Monoclonal antibodies : the second generation /
by: 186276 Zola, Heddy
Published: (1995)

Emerging Immunotherapies for Advanced Non-Small-Cell Lung Cancer
by: Emily Wolf, et al.
Published: (2025-01-01)

Bispecific Antibodies: A Smart Arsenal for Cancer Immunotherapies
by: Gihoon You, et al.
Published: (2021-07-01)

VERITAS: Harnessing the power of nomenclature in biologic discovery
by: Riti Biswas, et al.
Published: (2023-12-01)

Bispecific antibody drug conjugates: Making 1+1>2
by: Yilin Gu, et al.
Published: (2024-05-01)

Breaking the shield of solid tumors: a combined approach for enhanced efficacy of CAR-T cells
by: Marat Khaliulin, et al.
Published: (2024-11-01)

Clinical Management of Triple-Class Refractory Multiple Myeloma: A Review of Current Strategies and Emerging Therapies
by: Margaret E. Stalker, et al.
Published: (2022-06-01)

Monoclonal antibodies against Mycobacterium tuberculosis, detecting the antigen in urine of the pulmonary tuberculosis patients
by: A. V. Onyan, et al.
Published: (2016-02-01)

Chemoenzymatic site-selective attachment to antibodies: using glycosylation sites to post-translationally program function
by: Khan, MA
Published: (2021)

Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
by: Masaud Shah, et al.
Published: (2025-01-01)